Strongbridge Biopharma plc (SBBP)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

900 NORTHBROOK DRIVE, SUITE 200 TREVOSE, PA 19053

Strongbridge Biopharma PLC operates as a biopharmaceutical company focused on the development, in-licensing, acquisition and commercialization of complementary product candidates across multiple franchises that target rare diseases. The Company distributes their products globally.

Data as of 2020-10-17
Market Cap145.992 Million Shares Outstanding65.467 Million Avg 30-day Volume733.954 Thousand
P/E Ratio Dividend Yield EPS-1.06
Price/Sales7.285 Price cash flow ratio Price free cash flow ratio-5.1
Book Value0.73 Price to Tangible Book8.29 Alpha-0.02
Short Interest Ratio % Short Interest to Float R-squared0.114136
BETA1.72237 52-week High/Low4.63 / 1.43 Stddev0.215308
View SEC Filings from SBBP instead.
Q2 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 1 1 0.0% 0 (0.0%) 0 (0.0%)
Funds Holding: 70 61 14.75% 24 (1.57%) 18 (1.15%) 33.33%
13F shares: 27.916 Million 25.795 Million 8.22% 8.682 Million 8.225 Million 5.55%
% Ownership 51.3576 47.5501 8.01% 15.9718 15.1617 5.34%
New Positions: 15 13 15.38% 6 7 -14.29%
Increased Positions 25 20 25.0% 6 5 20.0%
Closed Positions 6 11 -45.45% 7
Reduced Positions 20 18 11.11% 10 6 66.67%
Total Calls 23.424 Thousand 529 4327.98% 13.1 Thousand
Total Puts 0 0
PUT/CALL Ratio 0.0 0.0 0.0
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding SBBP (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SBBP BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

1.5 Million total shares from 3 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

GILL DAVID N

  • Director
74,896 2020-09-24 3

CDK ASSOCIATES, L.L.C.

CAXTON CORP

KOVNER BRUCE

  • 10% Owner
8,060,682 2020-09-17 1

JOHNSON JOHN CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
522,152 2020-07-02 4

KONG GARHENG

  • Director
60,956 2020-05-15 2

STEINEGER HILDE H

  • Director
60,965 2020-05-15 2

SHERMAN JEFFREY W

  • Director
60,965 2020-05-15 2

STEEN MARTEN

  • Director
60,918 2020-05-15 2

KOLLENDER RICHARD S CHIEF OPERATING OFFICER

  • Officer
0 2020-01-27 1

COHEN FREDRIC J. CHIEF MEDICAL OFFICER

  • Officer
0 2020-01-27 1

LONG STEPHEN J CHIEF LEGAL OFFICER

  • Officer
0 2020-01-27 1

WILHOIT SCOTT L. CHIEF COMMERCIAL OFFICER

  • Officer
0 2020-01-27 1

LUTZ ROBERT MATTHEW CHIEF FINANCIAL OFFICER

  • Officer
0 2020-01-27 1

PAULS MATTHEW PRESIDENT & CEO

  • Officer
  • Director
72,608 2019-02-20 0

DAVIS A BRIAN CHIEF FINANCIAL OFFICER

  • Officer
33,366 2019-02-20 0

BARRETT M JAMES

  • 10% Owner
4,141,308 2018-01-01 0

GROWTH EQUITY OPPORTUNITIES FUND III, LLC

NEW ENTERPRISE ASSOCIATES 14, L.P.

NEA PARTNERS 14, L.P.

NEA 14 GP, LTD

  • 10% Owner
4,141,308 2018-01-01 0

SANDELL SCOTT D

  • 10% Owner
4,141,308 2018-01-01 0

MOTT DAVID M

  • 10% Owner
4,141,308 2018-01-01 0

KERINS PATRICK J

  • 10% Owner
4,141,308 2018-01-01 0

FLORENCE ANTHONY A. JR.

  • 10% Owner
4,141,308 2018-01-01 0

BASKETT FOREST

  • 10% Owner
4,141,308 2018-01-01 0

BARRIS PETER J

  • 10% Owner
4,141,308 2018-01-01 0

VISWANATHAN RAVI

  • 10% Owner
4,141,308 2018-01-01 0

SONSINI PETER W.

  • 10% Owner
4,141,308 2018-01-01 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

GILL DAVID N - Director

2020-09-28 07:48:17 -0400 2020-09-24 P 8,000 $2.13 a 74,896 direct -1.8605 0.4651 0.4651 6 -4.186 5

CDK ASSOCIATES, L.L.C. - > 10% Owner

CAXTON CORP - > 10% Owner

KOVNER BRUCE - > 10% Owner

2020-09-21 21:48:26 -0400 2020-09-18 P 6,000 $2.20 a 8,060,682 direct -1.8182 -4.0909 0.0 1 -4.0909 6

CDK ASSOCIATES, L.L.C. - > 10% Owner

CAXTON CORP - > 10% Owner

KOVNER BRUCE - > 10% Owner

2020-09-21 21:48:26 -0400 2020-09-17 P 1,473,377 $2.25 a 8,054,682 direct -1.8182 -4.0909 0.0 1 -4.0909 6

GILL DAVID N - Director

2020-09-04 16:28:26 -0400 2020-09-03 F 23,104 $3.61 d 66,896 direct 0.0 0.3546 -24.4681 0.3546 6 -26.9504 19

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments